🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for HIV/AIDS and Infections

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage NCT05939167Phase 1, Phase 24 sites📍 Beijing📍 Beijing📍 Shenzhen Cell Energy Life Sciences Group Co. LTD · Tests: mesenchymal stem cell, saline Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma NCT06857071NA1 site📍 Pietermaritzburg University of Illinois at Chicago · Tests: Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis NCT06590428NA1 site📍 East London Albert Einstein College of Medicine · Tests: Therapeutic Drug Monitoring for Linezolid Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy NCT07336797Phase 21 site📍 Cairo Abdelrahman Mahmoud · Tests: Empagliflozin (oral), Placebo Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Daratumumab SC Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) NCT07665372NA19 sites📍 Phoenix📍 Los Angeles📍 San Francisco Johns Hopkins University · Tests: HIV D+/R+, HIV D-/R+ Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health NCT06796686Phase 16 sites📍 San Francisco📍 Atlanta📍 Decatur National Institute of Allergy and Infectious Diseases (NIAI… · Tests: 426c.Mod.Core-C4b, HxB2.WT.Core-C4b, 3M-052-AF adjuvant, Aluminum hydroxide suspension (Alum) adjuvant, Diluent Precision Imaging to Evaluate Kaposi Sarcoma NCT06898203NA2 sites📍 Kisumu📍 Kampala Washington University School of Medicine · Tests: SkinScan3D Vienna HIV Infection Via Sex Study NCT05326061n/a1 site📍 Vienna Medical University of Vienna Analyses of Newly Diagnosed HIV Infection in Hong Kong NCT07725042n/a1 site📍 North Point Chinese University of Hong Kong Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise Training NCT04512456NA1 site📍 Rio de Janeiro Instituto Nacional de Cardiologia de Laranjeiras · Tests: Exercise training Paradoxical Tuberculosis Reactions in Patients Without HIV Infection NCT04052022n/a3 sites📍 Bethesda📍 Mexico City📍 Mexico City National Institute of Allergy and Infectious Diseases (NIAI… Feasibility of HPV Testing With Mail-delivered Sample Collection Kits NCT07087145n/a1 site📍 San Francisco University of California, San Francisco · Tests: Mail-based Saliva Sample Kit, Study-related Surveys Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH) NCT06501781NA2 sites📍 Washington D.C.📍 Baltimore University of Maryland, Baltimore · Tests: Peer Activate-LAI, Standard of Care HIV treatment or prevention with LAI-PrEP/ART Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 NCT07636928Phase 11 site📍 Groningen ViiV Healthcare · Tests: VH4524184, [14C]VH4524184 microdose, [14C]VH4524184 A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) NCT07202546Phase 2123 sites📍 Bakersfield📍 Palm Springs📍 West Hollywood ViiV Healthcare · Tests: VH4524184, Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets, Dolutegravir / Lam… Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population NCT00796146n/a1 site📍 Bangkok SEARCH Research Foundation Propranolol for the Treatment of Kaposi Sarcoma in Adults NCT06445166Phase 21 site📍 St Louis Washington University School of Medicine · Tests: Propranolol Hydrochloride Evaluating the Safety and Immunogenicity of MTBVAC NCT05947890Phase 216 sites📍 Johannesburg📍 Westdene📍 Durban HIV Vaccine Trials Network · Tests: MTBVAC, BCG Gathering Online for Dialogue and Discussion to Enhance Social Support NCT05753683NA1 site📍 Durham RTI International · Tests: mHealth-Women's CoOp, Virtual Group Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites📍 Duarte📍 Chicago📍 New York AIDS Malignancy Consortium · Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence NCT07772791NA1 site📍 Rio de Janeiro Oswaldo Cruz Foundation · Tests: Weekly WhatsApp Adherence Messages Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention NCT07076043Phase 41 site📍 Thika University of Alabama at Birmingham · Tests: Multiple Product PrEP Program, Routine Oral PrEP Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV NCT06375135NA1 site📍 Miami Florida International University · Tests: TXTXT, e-Navigation, Ecological Momentary Assessment (EMA) supported e-Navigation. Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand NCT07509853NA1 site📍 Pathum Wan Institute of HIV Research and Innovation Foundation, Thaila… · Tests: Pleasuremeter-guided qualitative interview, Pleasuremeter-based sexual pleasure discussion integrated with harm reducti… Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study NCT07512869n/a1 site📍 Pathum Wan Institute of HIV Research and Innovation Foundation, Thaila… · Tests: Self-administered questionnaire assessment, Semi-structured in-depth interviews (IDIs), Development and refinement of h… Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention NCT06005298NA1 site📍 Louisville Shirish S Barve · Tests: Screening, Brief Intervention, Referral to Treatment (SBIRT) Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV NCT04174755NA1 site📍 Dublin University College Dublin · Tests: Semaglutide Injectable Product, Standard of care Natural History Study of Kaposi Sarcoma NCT06375122n/a1 site📍 Bethesda National Cancer Institute (NCI) Boosting Olfactory and Sensory Training Study (BOOST) NCT07221123Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Conventional Smell Training Group, Scented Marker Group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy